Premier Foods (PFD) shares tick up 1.38% to 120.3p after 3Q21 surpasses expectations
On Thursday, the company published a trading update for the thirteen weeks ended 1 January 2022 in which it stated that the 3Q21 trading period was ahead of expectations.
CEO, Alex Whitehouse said the “strong momentum” from 1H21 had continued into the key 3Q trading period, with its brands growing by 11.3% compared to two years ago. He said this was well ahead of the market across all categories and resulted in “very encouraging share gains.”
He added: “With three strong quarters of trading now delivered and taking good momentum into the final quarter, we are increasing our profit expectations for this financial year.”
Pennant International Group (PEN) shares jump 21.54% to 39.5p as it is named key supplier
Pennant International, which provides training technology and integrated product support solutions, has been named as a key supplier by Boeing Defence United Kingdom (BDUK).
Its scope of work will be to deliver several new and upgraded Part Task Trainers which are compatible with the new fleet. The company told investors that alongside BDUK, both parties are presently working to finalise Pennant’s contract and that award is expected imminently.
Braveheart Investment Group (BRH) shares rise 18.18% to 26p as Paraytec upgrades platform
Braveheart’s investment portfolio company Paraytec has designed a short prospective clinical study to evaluate the performance of its CX300 platform technology. The Group said upgrades to the CX300 platform has indicated five-fold
improvement to its limit of detection.
As a result of these new indications, Braveheart said Paraytec will seek to confirm this improvement by the testing of swab specimens from patients with new cases of COVID-19.
Paraytec has designed a short prospective clinical study to evaluate the performance of the CX300, when measured not only against both PCR and lateral flow tests, but also by determining patient sample viral infectivity by culture on mammalian epithelial cells.
This trial will monitor positive patients daily for up to 10 days to establish the performance of the device in determining the presence of infectious virus. It is expected to start next month.
PHSC (PHSC) shares rise 13.51% to 21p as it unveils new £0.3m share buyback
Shares in the security systems services company PHSC jumped on Friday afternoon after the company announced a fresh share buyback program for up to £0.3m, equivalent to $0.408m.
The company’s decision to announce the share buyback, which will be for a maximum of 2 million shares, was taken following the previous successful buyback program back in 2021.